Net Cash Provided by (Used in) Financing Activities in USD of CASSAVA SCIENCES INC from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
CASSAVA SCIENCES INC quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • CASSAVA SCIENCES INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $90K, a 99.6% decline year-over-year.
  • CASSAVA SCIENCES INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $124M, a 4762% increase from 2023.
  • CASSAVA SCIENCES INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2.56M, a 94.6% decline from 2022.
  • CASSAVA SCIENCES INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $47.8M, a 75.1% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

CASSAVA SCIENCES INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $90K -$22.1M -99.6% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q1 2024 $22.2M +$22.1M +34525% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q1 2023 $64K -$147K -69.7% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q1 2022 $211K -$191M -99.9% 01 Jan 2022 31 Mar 2022 10-Q 01 May 2023
Q1 2021 $191M +$187M +5186% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q1 2020 $3.61M +$3.67M 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021
Q1 2019 -$60K -$1.96M -103% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020
Q1 2018 $1.9M 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019
Q1 2013 $6M 01 Jan 2013 31 Mar 2013 10-Q 24 Apr 2013
Q1 2011 $4.43M 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012

CASSAVA SCIENCES INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $124M +$122M +4762% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025
2023 $2.56M -$45.2M -94.6% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025
2022 $47.8M -$145M -75.1% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025
2021 $192M +$117M +155% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024
2020 $75.4M +$69.6M +1199% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 $5.81M -$8.29M -58.8% 01 Jan 2019 31 Dec 2019 10-K 23 Mar 2021
2018 $14.1M 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020
2016 -$284K 01 Jan 2016 31 Dec 2016 10-K 06 Feb 2018
2012 -$34.2M -$42.9M -493% 01 Jan 2012 31 Dec 2012 10-K 08 Feb 2013
2011 $8.7M +$92M 01 Jan 2011 31 Dec 2011 10-K 08 Feb 2013
2010 -$83.3M 01 Jan 2010 31 Dec 2010 10-K 08 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.